Lifting the lid on bladder cancer support

May 28, 2019

Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to talk about, with many becoming homebound as they cope with debilitating side effects such as incontinence.

Bladder cancer mainly starts between the ages of 50 and 80 years old, affecting men at a ratio of 3:1, and is increasing with an ageing population in Australia.

As with prostate and other male cancers, the majority of support and care is taken by the wife, spouse or an immediate family member.

The responsibility and burden of the couple's combined cancer 'journey' has been explored by researchers in nursing and medicine at Flinders University.

The study has underpinned a new model of care for people diagnosed with bladder cancer - focusing on their partners and family and their needs from the healthcare system - for use in urology and other settings.

While little discussed, bladder cancer is characterised by recurrence and progression so often needs ongoing surveillance and treatment.

Chronic ill health and complications associated with treatment can put additional pressure on the patient, as well as their spouse, partner and family, says College of

Nursing and Health Sciences researcher Dr Susan Heyes, who conducted qualitative research with 10 couples to assess their experiences.

Dr Heyes says the battle with bladder cancer can run over several decades, with the treatments, including chemo or surgery, and sometimes co-morbidities taking a toll on all involved.

"They are often too ill or in too much pain to be bothered with activities outside the home. It also can see a couple becoming quite confined to the home due to incontinence, which can discourage them from joining a club or community event as a result of the treatment and embarrassment of the condition.

"This may involve a frequent urge to urinate, which can catch them off-guard and perhaps look odd in public".

Despite continuous improvement in treatment options, outcomes usually involve long-term surveillance with repeated complications including possible muscle invasion by the cancer resulting in the removal of the bladder and possible death.

"Throughout the study, we found that a supportive partner was vital in dealing with the daily impacts of bladder cancer, and health professionals can capitalise on this in a number of ways," Dr Heyes says.

"Health professionals can help by giving partners and carers clear and concise information, counselling and support for patient management, with attention to individual and day-to-day needs."

Cancer nurses, doctors and other health professionals can therefore assist with managing the shock and fear of diagnosis, pre- and post-surgery issues, treatment and recovery, sexuality and body image, and support and comfort.
The latest paper, 'Toward an Understanding of Patients' and Their Partners' Experiences of Bladder Cancer', 2019, by SM Heyes, KN Prior, D Whitehead and MJ Bond (Flinders University), has been published online at Cancer Nursing.

The bladder cancer study is part of a series of journal articles and international conference presentations, with the full quantitative analysis under review along with a chapter in a new nursing and midwifery research textbook aiming to bring the key findings into general practice.

Flinders University

Related Bladder Cancer Articles from Brightsurf:

Effectiveness of gemcitabine & daily RT for bladder preservation in muscle-invasive bladder cancer
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for selected patients with muscle-invasive bladder cancer.

Anthrax may be the next tool in the fight against bladder cancer
Researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors.

Effectiveness of a new bladder cancer treatment demonstrated
Demonstrated the effectiveness of a drug for treating metastatic bladder cancer in patients who did not respond to the usual treatment.

Lifting the lid on bladder cancer support
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to talk about, with many becoming homebound as they cope with debilitating side effects such as incontinence.

How genomics profiling can help identify the best treatment for bladder cancer
A new computational tool -- a single-patient classifier -- effectively enables physicians to assign a bladder cancer subtype to an individual patient's cancer using that patient's genomic data.

Early menopause in smokers linked to bladder cancer
Research shows that experiencing menopause before the age of 45 is associated with a higher risk of bladder cancer.

Olfactory receptor as therapeutic target in bladder cancer
Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.

Bladder cancer model could pave the way for better drug efficacy studies
In the journal Cancer Research, UNC Lineberger Comprehensive Cancer Center researchers report they have developed a model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer.

Genetic fixer-uppers may help predict bladder cancer prognosis
Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers, who found that bladder cancer patients who had mutations in their ATM or RB1 genes -- proteins that help repair DNA damage when they're functioning normally -- tended not to live as long as patients without the mutations.

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer
Researchers from Mount Sinai and Sema4, a health information company and Mount Sinai venture, have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumors have certain genetic mutations may respond particularly well to this combination approach, according to the results of a clinical trial published in European Urology.

Read More: Bladder Cancer News and Bladder Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to